Bagsværd, Denmark and Redmond, WA, US, 12 September 2022 - Novo Nordisk and Microsoft have entered a new strategic collaboration to combine Microsoft's computational services, cloud and artificial
Novo Nordisk and Microsoft have entered a new strategic collaboration to combine Microsoft’s computational services, cloud and artificial intelligence (AI) with Novo Nordisk’s drug discovery, development and data science capabilities. Through the partnership, Microsoft is providing AI technology, foundational .
Bagsværd, Denmark and Redmond, WA, US, 12 September 2022 – Novo Nordisk and Microsoft have entered a new strategic collaboration to combine Microsoft’s.
Investegate announcements from Novo Nordisk A/S, Novo Nordisk and Microsoft collaborate to accelerate drug discovery and development using big data and artificial intelligence
Novo Nordisk and Microsoft have entered a new strategic collaboration to combine Microsoft’s computational services, cloud and artificial intelligence (AI) with Novo Nordisk’s drug discovery, development and data science capabilities. Through the partnership, Microsoft is providing AI technology, foundational science models and expertise and is working alongside Novo Nordisk’s data scientists and domain experts from early research and development areas to accelerate Novo Nordisk’s R&D.